|4/AFeb 18, 6:50 PM ET

AGARWAL SUNIL 4/A

4/A · Sana Biotechnology, Inc. · Filed Feb 18, 2021

Insider Transaction Report

Form 4/AAmended
Period: 2021-02-03
AGARWAL SUNIL
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-03+76,68276,682 total
    Exercise: $25.00Exp: 2031-02-02Common Stock (76,682 underlying)
Footnotes (2)
  • [F1]This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.
  • [F2]The option vests and becomes exercisable as to 25% of the underlying shares on February 15, 2022 and in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION